Knee Replacement With Diabetes: What Patients Need to Know Before Surgery

Illustration: Key preparation factors before knee replacement for a patient with diabetes. Medical review by Dr. Mayur Rabhadiya.

Many people with diabetes can safely undergo knee replacement when the operation is clinically indicated and their medical risks are assessed and optimised. Diabetes is not an automatic reason to avoid surgery. Persistent hyperglycaemia, however, can increase the risk of wound problems, infection, medical complications and readmission. Preparation therefore involves more than obtaining a single HbA1c value: it requires a coordinated plan for glucose, medicines, associated illnesses, surgery and recovery.

This guide explains how diabetes affects knee replacement preparation, what HbA1c and daily glucose readings mean, how medicines are handled, when surgery may reasonably be delayed, and why robotic assistance or a muscle-sparing approach cannot replace medical optimisation. For the broader decision about whether surgery is appropriate, read the knee replacement surgery in Mumbai guide.

Can a Person With Diabetes Have Knee Replacement?

Yes. A person with type 1 or type 2 diabetes may be a suitable candidate when knee arthritis is the principal source of pain and disability, appropriate non-surgical treatment has not provided enough relief, and the expected benefit justifies the individual risk. The assessment should combine symptoms, examination, weight-bearing X-rays, functional limitation, medical fitness and patient goals.

Diabetes changes preparation and postoperative surveillance; it does not determine whether the knee itself needs replacement. An abnormal X-ray alone does not justify surgery, and a favourable HbA1c alone does not prove that surgery is necessary. Patients who may still benefit from exercise, weight management, medicines or selected injections can review the non-surgical knee arthritis treatment options before deciding on replacement.

Why Diabetes Matters Before Knee Replacement

Diabetes can affect immune function, wound healing and the body’s response to surgical stress. It may coexist with kidney disease, cardiovascular disease, obesity, neuropathy, anaemia or nutritional problems, each of which can influence anaesthesia, rehabilitation and postoperative risk.

Systematic reviews of total knee arthroplasty report higher average risks of periprosthetic joint infection, venous thromboembolism and readmission among patients with diabetes. These are group-level associations, not predictions for one individual. Risk varies with glucose control, diabetes type and duration, other illnesses, skin condition, surgical factors and perioperative care. The practical objective is to identify modifiable risk rather than assume that every person with diabetes has the same outcome.

HbA1c Before Knee Replacement: Important, but Not a Pass-Fail Test

HbA1c estimates average glucose exposure over approximately the previous two to three months. The American Diabetes Association’s 2026 hospital-care standards recommend an individualised preoperative HbA1c goal below 8% within three months of elective surgery. Hospitals and surgical teams may use different thresholds according to the procedure, associated illness and local policy.

A single HbA1c value has limitations. Anaemia, kidney disease, altered red-cell turnover and some haemoglobin disorders can affect interpretation. HbA1c also does not show day-to-day variability or recent hypoglycaemia. It should therefore be considered with home glucose readings or continuous glucose monitoring data, renal function, medication safety, nutrition, skin integrity and the likely benefit of surgery.

The ADA recommends a perioperative glucose range of approximately 100–180 mg/dL for most patients. This is a clinical target used by the medical and anaesthetic team, not a number a patient should attempt to reach by changing medicines without supervision.

What Should Be Assessed Before Surgery?

A diabetes-specific preoperative assessment should confirm that arthritis is the main pain source and review recent HbA1c, daily glucose patterns, diabetes type and duration, previous ketoacidosis or severe hypoglycaemia, the current treatment regimen, kidney function, blood pressure, cardiovascular history, haemoglobin, nutrition, skin integrity, foot problems, active ulcers or infection, smoking or nicotine exposure, mobility, fall risk and home support.

There should also be a written plan for medicines, fasting, glucose monitoring, insulin correction and postoperative follow-up. A patient should know which factor needs improvement, what target is being used, who is responsible for managing it and when it will be reviewed. General operative risks are explained in the knee replacement risks and complications guide.

How Are Diabetes Medicines Managed Around Surgery?

Medication planning must be individualised by the treating physician, anaesthetist and surgical team. Insulin doses may need adjustment because fasting, surgical stress, intravenous fluids and reduced appetite can all change glucose requirements. Oral medicines are commonly modified or withheld around the operation.

Some medicines, particularly SGLT2 inhibitors, require advance interruption because of perioperative ketoacidosis risk. GLP-1 receptor agonist decisions depend on the medicine, dosing schedule, gastrointestinal symptoms and current anaesthesia guidance. Patients should not stop insulin or other diabetes medicines independently. The written plan should specify the final preoperative dose, what to do if glucose is unexpectedly high or low, how often glucose will be checked and when the usual regimen will restart.

What Happens on the Day of Surgery and in Hospital?

The hospital team should verify glucose, fasting status, medicines taken, recent hypoglycaemia and any new infection or skin problem. Glucose is monitored during the perioperative period and treated according to protocol. The anaesthetic plan, antibiotic prophylaxis, thrombosis prevention, pain control, hydration and nutrition should reflect the patient’s medical profile.

After surgery, stress hormones can temporarily increase glucose even in a patient who was well controlled at home. Reduced food intake can also cause hypoglycaemia if insulin or medicines are not adjusted. Regular measurement is therefore safer than assuming that the usual home regimen remains appropriate.

Does Robotic Knee Replacement Reduce Diabetes-Related Risk?

Robotic assistance can support patient-specific planning, component positioning and execution. It does not correct hyperglycaemia, improve immune function or eliminate wound and infection risk. The indication for surgery, diabetes optimisation, sterile technique, antibiotic strategy, soft-tissue handling and postoperative monitoring remain essential. Read more about the role and limitations of robotic knee replacement in Mumbai.

A mini-subvastus approach aims to preserve the quadriceps mechanism by working beneath the vastus medialis in selected patients. It is a surgical-exposure decision, not a metabolic treatment. A muscle-sparing approach may support early functional recovery for suitable patients, but it cannot neutralise diabetes-related medical risk. Safe exposure and sound clinical judgement take priority over incision length or marketing labels.

When Might Knee Replacement Be Delayed?

A delay may be reasonable when a modifiable problem creates avoidable risk. Examples include persistently uncontrolled glucose, recurrent severe hypoglycaemia, recent ketoacidosis, an active skin ulcer or infection, major untreated anaemia, unstable cardiac symptoms or incomplete medication planning.

Delay should not be automatic or open-ended. The reason, target, treatment plan and reassessment date should be explained. In some patients, prolonged immobility and severe pain also carry consequences, so the decision balances the risk of proceeding with the risk of waiting. A structured knee replacement second opinion can help when different thresholds or recommendations have been given.

Recovery and Wound Care at Home

Patients with diabetes should receive clear instructions for glucose monitoring, meals, medicines, wound care, physiotherapy and whom to contact. Appetite and activity can change during the first days after surgery, so the usual diabetes regimen may need temporary adjustment. Adequate protein and calorie intake, hydration and progressive mobility can support recovery, but advice must be adapted for kidney, cardiac or other dietary restrictions.

Urgent medical review is required for increasing wound redness, drainage, fever, rapidly worsening pain, a hot swollen joint, persistent very high or very low glucose, vomiting or symptoms suggestive of ketoacidosis. New calf swelling, chest pain or breathlessness also requires urgent assessment.

Questions to Ask Before Knee Replacement With Diabetes

Ask what your current HbA1c means in context, which glucose range the hospital will aim for, exactly which medicines should be taken or withheld, whether kidney, heart, nerve or foot complications alter the plan, which infection concerns require treatment, who will manage glucose after discharge, and which symptoms should prompt urgent review.

Frequently Asked Questions

Can diabetes prevent me from having knee replacement?

Not automatically. Diabetes is one component of risk assessment. Surgery may be reasonable when arthritis causes substantial disability, the expected benefit is meaningful and glucose and associated medical problems are managed as safely as possible.

What HbA1c is acceptable before knee replacement?

The ADA’s 2026 standards recommend an individualised goal below 8% within three months of elective surgery, but this is not a universal pass-fail threshold. The result should be interpreted with daily glucose patterns, anaemia, kidney function, hypoglycaemia and overall health.

Does diabetes increase infection risk after knee replacement?

On average, studies associate diabetes with a higher risk of periprosthetic joint infection and some other complications. Individual risk is influenced by glucose control, skin integrity, obesity, kidney or vascular disease, smoking, surgical factors and perioperative care.

Should I stop diabetes medicines before surgery?

Only according to a written plan from the medical and anaesthetic team. Different medicines require different handling, and stopping insulin or other treatment without supervision can be dangerous.

Will robotic surgery remove diabetes-related risk?

No. Robotic assistance can improve planning and execution precision, but it does not remove diabetes-related wound, infection or medical risk. Technology is one component of a broader surgical and perioperative pathway.

Can surgery be postponed until glucose control improves?

Yes, when poor control or another modifiable problem creates avoidable risk. Any delay should have a defined reason, treatment plan, target and review date rather than being indefinite.

Practical Conclusion

Knee replacement with diabetes is not a simple yes-or-no decision based on one HbA1c result. A sound plan confirms that replacement is truly indicated, assesses diabetes and associated illness, coordinates medication and glucose management, and prepares the patient for wound care and rehabilitation. Robotic assistance and a mini-subvastus approach may support technical execution and early function in selected patients, but neither replaces medical optimisation or realistic counselling.

Clinical References

1. American Diabetes Association Professional Practice Committee. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). doi:10.2337/dc26-S016.

2. Vaishya R, et al. Outcomes of total knee arthroplasty in people with diabetes: An overview of systematic reviews and meta-analysis. Journal of Orthopaedics. 2025;65:336–345. doi:10.1016/j.jor.2025.06.023.

3. Li J, et al. Risk factors for periprosthetic joint infection following primary total knee arthroplasty: a systematic review and meta-analysis. Frontiers in Surgery. 2026;12:1715571. doi:10.3389/fsurg.2025.1715571.

About the Author

Written and medically reviewed by Dr. Mayur Rabhadiya, MBBS, D’Ortho, DNB (Orthopedics), MNAMS (Orthopedics), FIJR (Robotic & Navigation). Dr. Rabhadiya is an Orthopedic & Robotic Joint Replacement Surgeon in Ghatkopar, Mumbai, with a clinical focus on knee arthritis assessment, evidence-based non-surgical care, and minimally invasive mini-subvastus robotic knee replacement for selected patients.

Last medically reviewed: 27 July 2026. This article provides general medical education and does not replace an individual examination, imaging review, diabetes assessment or anaesthetic consultation.